CBM - Cambrex Corporation

NYSE - NYSE Delayed Price. Currency in USD
55.95
+0.60 (+1.08%)
At close: 4:02PM EDT

55.95 0.00 (0.00%)
After hours: 5:00PM EDT

Stock chart is not supported by your current browser
Previous Close55.35
Open55.45
Bid0.00 x 3000
Ask0.00 x 1200
Day's Range55.40 - 57.60
52 Week Range42.55 - 62.30
Volume581,649
Avg. Volume353,577
Market Cap1.844B
Beta2.26
PE Ratio (TTM)17.59
EPS (TTM)3.18
Earnings DateAug 2, 2018 - Aug 6, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2007-05-04
1y Target Est60.75
Trade prices are not sourced from all markets
  • See what the IHS Markit Score report has to say about Cambrex Corp.
    Markit4 days ago

    See what the IHS Markit Score report has to say about Cambrex Corp.

    This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on June 26. Index (PMI) data, output in the Basic Materials sector is rising.

  • GlobeNewswire16 days ago

    Cleantech Building Materials: China Distribution and Offtake agreement

    Cleantech Building Materials plc ("CBM" or the "Company") is pleased to announce that CBM`s subsidiary, Diamond Wood China Limited ("Diamond Wood"), has entered into a Distribution and Offtake Agreement with Wise Technology of China ("WISE") (the "Agreement"). Under the terms of the Agreement, WISE has committed to purchase a significant volume of Accoya® wood from Diamond Wood to be sold to manufacturers and project contractors in China`s Northern regions and Southern interior regions of Sichuan and Chongqing provinces.

  • See what the IHS Markit Score report has to say about Cambrex Corp.
    Markit20 days ago

    See what the IHS Markit Score report has to say about Cambrex Corp.

    Index (PMI) data, output in the Basic Materials sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.

  • Is Cambrex Corporation (NYSE:CBM) A Buy At Its Current PE Ratio?
    Simply Wall St.22 days ago

    Is Cambrex Corporation (NYSE:CBM) A Buy At Its Current PE Ratio?

    This analysis is intended to introduce important early concepts to people who are starting to invest and want to begin learning the link between Cambrex Corporation (NYSE:CBM)’s fundamentals and stockRead More...

  • See what the IHS Markit Score report has to say about Cambrex Corp.
    Markit25 days ago

    See what the IHS Markit Score report has to say about Cambrex Corp.

    Index (PMI) data, output in the Basic Materials sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.

  • GlobeNewswire28 days ago

    New Research: Key Drivers of Growth for Winnebago Industries, SkyWest, Brightcove, Selective Insurance Group, Reinsurance Group of America, and Cambrex — Factors of Influence, Major Initiatives and Sustained Production

    NEW YORK, June 20, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Winnebago ...

  • GlobeNewswirelast month

    Cambrex Expands Generic API Research and Development Capabilities at Milan, Italy Site

    Cambrex Corporation (CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it will expand research and development capabilities at its site in Paullo, Milan, Italy. The investment will be in the construction of a new 150m² R&D laboratory and the recruitment of additional scientists to increase the number of generic APIs in the company’s development portfolio. The new laboratory will include 14 fume hoods and will combine both chemistry and analytical development capabilities, with the installation of glass lined reactors, as well as analytical instruments including multiple high and ultra-performance liquid chromatography, and gas chromatography systems.

  • GlobeNewswire2 months ago

    Cambrex to Present at the Jefferies 2018 Global Healthcare Conference

    EAST RUTHERFORD, N.J., June 01, 2018-- Cambrex Corporation, a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients, today announced that Steven Klosk, President ...

  • GlobeNewswire2 months ago

    Cambrex Invests $5 Million in New Laboratory Expansion at its Karlskoga, Sweden Facility

    Cambrex Corporation (CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it is to commence a $5 million expansion of laboratory facilities at its Karlskoga, Sweden site, to augment capability and capacity for process development and scale up, handling of potent substances, crystallization studies and solid phase characterization. The expansion will create space for a new technical laboratory with walk-in hoods for large scale laboratory syntheses up to 10 liters, where engineers and chemists will undertake tech transfer studies. The new investment will also enable handling of potent substances at a large laboratory scale, high pressure reactions and parallel synthesis for API route scouting and development.

  • GlobeNewswire2 months ago

    Cambrex Completes Pilot Plant Expansion at its High Point, NC Facility

    Cambrex Corporation (CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it has completed a pilot plant expansion at its High Point, NC facility with the installation and commissioning of a fourth reactor suite, increasing the site's reactor capacity by around 30%. The new 400 sq. ft. suite includes two 2,000 liter glass lined reactors and a 0.6 sq. m. Hastelloy C22 filter dryer, allowing the manufacture of batch sizes typically 10-100kg under cGMP conditions for clinical phase projects. The High Point site has also completed and implemented an upgrade of its analytical chromatography data systems for QC and analytical R&D to new, Empower 3 software.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of CBM earnings conference call or presentation 3-May-18 12:30pm GMT

    Q1 2018 Cambrex Corp Earnings Call

  • Associated Press2 months ago

    Cambrex: 1Q Earnings Snapshot

    On a per-share basis, the East Rutherford, New Jersey-based company said it had net income of 72 cents. Earnings, adjusted for non-recurring gains, came to 37 cents per share. The life sciences company ...

  • GlobeNewswire2 months ago

    Cambrex Reports First Quarter 2018 Financial Results

    -Net Revenue increased 34% vs. prior year quarter, which includes a favorable impact from the adoption of ASC 606-. -2018 full year financial guidance reaffirmed-. -Conference call at 8:30 a.m. ET on May ...

  • GlobeNewswire3 months ago

    Investor Expectations to Drive Momentum within Blackbaud, Pieris Pharmaceuticals, Sarepta Therapeutics, Cambrex, Stoneridge, and First Interstate BancSystem — Discovering Underlying Factors of Influence

    NEW YORK, April 27, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...

  • GlobeNewswire3 months ago

    Cleantech Building Materials: Results of Annual General Meeting

    27 April 2018 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH, COPENHAGEN TICKER: CBM Cleantech Building Materials plc Results of Annual General Meeting The Annual General Meeting ("AGM") ...

  • GlobeNewswire3 months ago

    Cambrex to Announce First Quarter 2018 Financial Results on May 3, 2018

    EAST RUTHERFORD, N.J., April 26, 2018-- Cambrex Corporation, a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients, today announced that first quarter 2018 financial ...

  • GlobeNewswire3 months ago

    Cambrex Completes New $3.2 Million Analytical Research & Development Laboratory at its High Point, NC Facility

    Cambrex Corporation (CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it has completed the construction and validation of a new $3.2 million, 11,000 sq.ft. analytical laboratory at its High Point, NC facility. The investment was driven by a growing customer demand for analytical development and validation services in support of clinical stage cGMP products. The expansion required the sourcing, acquisition, installation and qualification of more than 20 new analytical instruments, including HPLCs, mass spectrometers and support equipment.

  • GlobeNewswire3 months ago

    Cambrex Corporation to Provide Additional Information Regarding its Environmental, Social and Governance Practices

    EAST RUTHERFORD, N.J., April 19, 2018-- Cambrex Corporation, a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients, today announced a commitment to provide its ...

  • See what the IHS Markit Score report has to say about Cambrex Corp.
    Markit3 months ago

    See what the IHS Markit Score report has to say about Cambrex Corp.

    This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on February 13. Over the last one-month, outflows of investor capital in ETFs holding CBM totaled $760 million.

  • GlobeNewswire3 months ago

    Cleantech Building Materials: Notice of AGM

    3 April 2018 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH, COPENHAGEN TICKER: CBM CLEANTECH BUILDING MATERIALS PLC Notice of AGM Cleantech Building Materials plc ("CBM" or the "Company") ...

  • GlobeNewswire4 months ago

    Cleantech Building Materials: Annual Results to 31 December 2017

    29 March 2018 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH, COPENHAGEN TICKER: CBM Cleantech Building Materials plc Annual Results to 31 December 2017 Cleantech Building Materials plc ("CBM" ...

  • GlobeNewswire4 months ago

    Cleantech Building Materials: Application to Wiener Börse

    19 March 2018 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH, COPENHAGEN TICKER: CBM Cleantech Building Materials plc Application to Wiener Börse Cleantech Building Materials plc ("CBM" ...

  • ACCESSWIRE4 months ago

    Free Post Earnings Research Report: Cambrex Achieved Record Quarterly Revenue; EPS Climbed 4%

    Stock Monitor: Coherus Biosciences Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 16, 2018 / Active-Investors.com has just released a free earnings report on Cambrex Corp. (NYSE: CBM ). If you ...

  • GlobeNewswire4 months ago

    Cleantech Building Materials: Application to Wiener Börse

    16 March 2018 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH, COPENHAGEN TICKER: CBM Cleantech Building Materials plc Application to Wiener Börse Cleantech Building Materials plc ("CBM" ...